New York PostA British start-up hopes it’ll lead patients suffering from severe depression on a magical trip back to better mental health. Compass Pathways of London is about to launch a 400-Patient trial to determine if psilocybin, the active ingredient in magic … …read more Source:: Startup Tech News From Google News